Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Bio-Techne Cp (TECH)

Bio-Techne Cp (TECH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 7,105,733
  • Shares Outstanding, K 37,873
  • Annual Sales, $ 714,010 K
  • Annual Income, $ 96,070 K
  • 60-Month Beta 1.17
  • Price/Sales 10.15
  • Price/Cash Flow 32.80
  • Price/Book 6.22

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/19
See More
  • Average Estimate 0.89
  • Number of Estimates 1
  • High Estimate 0.89
  • Low Estimate 0.89
  • Prior Year 0.78
  • Growth Rate Est. (year over year) +14.10%

Price Performance

See More
Period Period Low Period High Performance
1-Month
183.15 +2.44%
on 08/06/19
216.03 -13.15%
on 07/29/19
-20.40 (-9.81%)
since 07/23/19
3-Month
183.15 +2.44%
on 08/06/19
217.15 -13.60%
on 07/03/19
-10.24 (-5.18%)
since 05/23/19
52-Week
132.75 +41.33%
on 12/24/18
217.15 -13.60%
on 07/03/19
-0.32 (-0.17%)
since 08/23/18

Most Recent Stories

More News
Look for Shares of Bio-Techne Corp to Potentially Rebound after Yesterday's 1.44% Sell Off

Bio-Techne Corp (NASDAQ:TECH) traded in a range yesterday that spanned from a low of $190.34 to a high of $194.74. Yesterday, the shares fell 1.4%, which took the trading range below the 3-day low of...

TECH : 187.62 (-1.99%)
Bio-Techne Introduces Maurice Empower® Control Kit For The Maurice(TM) System

Bio-Techne Corporation (NASDAQ: TECH) today announced the release of the Maurice Empower® Control Kit for the ProteinSimple(TM)-branded Maurice platform. This new kit enables users to collect, manage...

TECH : 187.62 (-1.99%)
Bio-Techne Corp Rises 2.85% on Heavy Volume: Watch For Potential Pullback

Bio-Techne Corp (NASDAQ:TECH) traded in a range yesterday that spanned from a low of $194.76 to a high of $198.35. Yesterday, the shares gained 2.9%, which took the trading range above the 3-day high...

TECH : 187.62 (-1.99%)
Bio-Techne To Present At The Baird 2019 Global Healthcare Conference

Bio-Techne Corporation (NASDAQ:TECH) today announced that Chuck Kummeth, President and Chief Executive Officer, will present at the Baird 2019 Global Healthcare Conference on Wednesday, September 4, 2019,...

TECH : 187.62 (-1.99%)
New Strong Sell Stocks for August 15th

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today.

ASB : 18.87 (-2.93%)
TECH : 187.62 (-1.99%)
CJ : 8.93 (-4.29%)
TSG : 14.07 (-1.47%)
ALGN : 175.04 (-2.20%)
Bio-Techne And Cygnus Technologies Announce Partnership For 3G CHO-HCP Assay

Bio-Techne Corporation and Cygnus Technologies, part of Maravai LifeSciences, announced today a strategic partnership for the quantification of Chinese hamster ovary host cell proteins (CHO-HCP) on the...

TECH : 187.62 (-1.99%)
Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)?

Sector ETF report for PBE

TECH : 187.62 (-1.99%)
PBE : 49.41 (-2.89%)
IBB : 102.41 (-2.62%)
AMGN : 199.08 (-2.13%)
XBI : 79.44 (-2.67%)
BIIB : 225.85 (-2.68%)
Bio-Techne Corp Falls 2.36% on Heavy Volume: Watch For Potential Rebound

Bio-Techne Corp (NASDAQ:TECH) traded in a range yesterday that spanned from a low of $188.21 to a high of $198.05. Yesterday, the shares fell 2.4%, which took the trading range below the 3-day low of...

TECH : 187.62 (-1.99%)
Techne (TECH) Q4 Earnings and Revenues Lag Estimates

Techne (TECH) delivered earnings and revenue surprises of -4.58% and -3.20%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

TECH : 187.62 (-1.99%)
Bio-Techne Releases Fourth Quarter Fiscal 2019 Results

Bio-Techne Corporation (NASDAQ:TECH) today reported its financial results for the fourth quarter ended June 30, 2019.

TECH : 187.62 (-1.99%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

See More Share

Trade TECH with:

Business Summary

Bio-Techne Corporation is a global life sciences company. It develops, manufactures, and sells biotechnology products and clinical diagnostic controls. It provides proteins, such as cytokines, growth factors, and enzymes; antibodies, including polyclonal and monoclonal antibodies; immunoassays comprising...

See More

Key Turning Points

2nd Resistance Point 192.50
1st Resistance Point 190.06
Last Price 187.62
1st Support Level 186.08
2nd Support Level 184.54

See More

52-Week High 217.15
Last Price 187.62
Fibonacci 61.8% 184.91
Fibonacci 50% 174.95
Fibonacci 38.2% 164.99
52-Week Low 132.75

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar